CINECA IRIS Institutional Research Information System

CORSO, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.986
EU - Europa 1.577
AS - Asia 947
SA - Sud America 27
OC - Oceania 21
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.953
CN - Cina 567
IT - Italia 527
IE - Irlanda 185
SE - Svezia 164
DE - Germania 161
FR - Francia 130
SG - Singapore 117
UA - Ucraina 84
FI - Finlandia 77
GB - Regno Unito 68
KR - Corea 68
JP - Giappone 51
PL - Polonia 51
VN - Vietnam 45
NL - Olanda 37
IN - India 32
CA - Canada 23
BE - Belgio 21
HK - Hong Kong 17
AU - Australia 16
AT - Austria 14
ES - Italia 11
IR - Iran 11
TW - Taiwan 11
PT - Portogallo 9
RU - Federazione Russa 9
BR - Brasile 8
TR - Turchia 8
CL - Cile 7
CH - Svizzera 6
IL - Israele 6
GR - Grecia 5
KE - Kenya 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
AR - Argentina 4
DK - Danimarca 4
GT - Guatemala 4
MX - Messico 4
LK - Sri Lanka 3
PE - Perù 3
SN - Senegal 3
TH - Thailandia 3
CO - Colombia 2
EU - Europa 2
HU - Ungheria 2
MY - Malesia 2
RO - Romania 2
SI - Slovenia 2
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MM - Myanmar 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.572
Salva come PNG Salva come JPEG
Città #
Chandler 327
Ann Arbor 313
Houston 267
Fairfield 266
Beijing 206
Dublin 185
Woodbridge 140
Ashburn 106
Wilmington 104
Seattle 100
Cambridge 99
Torino 85
Nyköping 74
Dearborn 67
Villeurbanne 63
Singapore 57
Jacksonville 53
Medford 53
Princeton 52
Pisa 50
Warsaw 47
Turin 46
Nanjing 45
Milan 41
Shanghai 37
Guangzhou 31
Dong Ket 28
New York 28
Redwood City 27
Boston 25
Hangzhou 25
Groningen 22
San Diego 20
Brussels 17
Los Angeles 15
Boardman 14
Fremont 14
Vienna 14
Jinan 13
Tokyo 13
Florence 12
Rome 12
Carrara 11
Munich 11
Zhengzhou 11
London 10
Chengdu 9
Hefei 9
Mumbai 9
Seoul 9
Genoa 8
Kunming 8
Verona 8
Wuhan 8
Changsha 7
Hebei 7
Hong Kong 7
Nanchang 7
Norwalk 7
Ottawa 7
Paris 7
San Jose 7
Upper Marlboro 7
Amsterdam 6
Falls Church 6
Helsinki 6
San Antonio 6
Silver Spring 6
Taipei 6
Washington 6
Barcelona 5
Salerno 5
San Mateo 5
Varese 5
Chongqing 4
Delhi 4
Duncan 4
Eitensheim 4
Gainesville 4
Norwich 4
Nürnberg 4
Phoenix 4
Rajkot 4
Reston 4
Tampa 4
Temuco 4
Tianjin 4
Trento 4
Tuglie 4
Xian 4
Banqiao 3
Bariloche 3
Bethesda 3
Brescia 3
Buffalo 3
Cagliari 3
Caluire-et-Cuire 3
Chuo 3
Farnborough 3
Fontenay-sous-bois 3
Totale 3.543
Salva come PNG Salva come JPEG
Nome #
How Can Gastric Cancer Molecular Profiling Guide Future Therapies? 391
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 278
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 267
Enhanced c-Met activity promotes G-CSF induced mobilization of hematopoietic progenitor cells via ROS signaling. 246
Only a subset of Met-activated pathways are required to sustain oncogene addiction 238
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study 226
Personalized therapeutic strategies in HER2-driven gastric cancer 220
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 209
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 201
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. 189
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 178
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 171
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors. 169
Istologia Medica 152
The tetraspanin CD151 is required for met-dependent signaling and tumor cell growth 142
Activation of RAS family members confers resistance to ROS1 targeting drugs. 132
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. 125
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort 116
Targeted therapies in cancer and mechanisms of resistance. 114
Targeted therapies for gastric cancer: failures and hopes from clinical trials 106
MicroRNAs impair MET-mediated invasive growth 105
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells. 83
Cytokine Induced Killer cells immunotherapy overcomes the resistance to MET tyrosine kinase inhibitors in nonsmall cell lung cancer 83
The Semaphorin 4D receptor controls invasive growth by coupling with Met 81
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility 76
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer 76
The landscape of d16HER2 splice variant expression across HER2-positive cancers 68
HGF/MET signaling protects Plasmodium infected host cells from apoptosis 66
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages 63
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 63
Semaphorin 4D regulates gonadotropin hormone-releasing Hormone-1 neuronal migration through Plexin B1-Met Complex 62
Autocrine signaling of NRP1 ligand galectin-1 elicits resistance to BRAF-targeted therapy in melanoma cells 60
Hepatocyte growth factor and its receptor are required for malaria infection 58
Patient-derived cancer models 58
Silencing the MET oncogene leads to regression of experimental tumors and metastases 56
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers 56
Cancer therapy: can the challenge be MET? 54
Hepatocyte growth factor/met system 54
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 52
MET overexpression turns human primary osteoblasts into osteosarcomas 52
Sema4D induces angiogenesis through Met recruitment by Plexin B1 50
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling 49
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling 49
Interplay between scatter factor receptors and B plexins controls invasive growth 47
Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS) 45
Molecularly targeted therapies for gastric cancer. State of the art 45
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence. 42
HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial 39
Microsatellite instability in Gastric Cancer: Between lights and shadows 38
The importance of being CAFs (in cancer resistance to targeted therapies) 36
Oncogenes and tumor suppressor genes 33
Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review 25
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors 22
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer 13
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 3
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations 3
Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair 3
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models 2
Totale 5.740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.717
article - articoli 0
book - libri 0
conference - conferenze 278
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.995
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020872 0 31 47 107 78 196 104 74 90 55 56 34
2020/2021666 39 46 47 76 38 32 90 40 58 58 42 100
2021/20221.096 74 81 86 78 58 45 63 58 48 82 256 167
2022/20231.111 103 97 37 86 131 240 75 63 118 25 76 60
2023/2024632 80 102 31 42 47 64 29 41 21 40 64 71
2024/202540 25 15 0 0 0 0 0 0 0 0 0 0
Totale 5.740